CPHI & P-MEC China is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The biopharmaceutical industry is undergoing rapid transformation, with breakthrough therapies and technologies driving a new wave of innovation. This forum brings together experts from policy, research, clinical and commercial sectors to explore key challenges and future opportunities — from regulation to real-world application.
Join leaders from global pharmaceutical companies, biotech, investment, and regulatory bodies as we map the future of biopharmaceutical development.
Agenda - Day 1
Advanced Biopharmaceutical Market and Prospect Analysis
Speaker:
Shen Siyu, Deputy General Manager of Consulting Division, China National Chemical Information Center
Speaker:
Ma He, Project Manager of Consulting Division, China National Chemical Information Center
Speaker:
Xia Jueyu, Chief Strategy Officer and Deputy General Manager of Tuohong Kangheng
Speaker:
Professor Wang Minyan, Professor at Xi'an Jiaotong-Liverpool University School of Science and Director of Neurobiology Research Center
Speaker:
Hao Shuai, Consulting Director of Life Sciences Division for Greater China, Frost & Sullivan
25th June 9:30-10:00
Interpretation of Guidelines/Evaluation Standards for Biopharmaceutical/Biological Innovative Drugs
Speaker:
Regulatory/Review Expert
25th June 10:00-10:30
International Cooperation Trends and Strategies for Biopharmaceuticals Under New Global Circumstances
Speaker:
MNC Expert
25th June 10:30-11:00
Global Pharmaceutical R&D & Market Trends
Speaker:
Manoj Kumar Pananchukunnath, Chief Scientific Officer Scientific Affairs, Biocon Limited
25th June 11:00-11:30
Supporting Early Phase Clinical Trails in Australia
Speaker:
Tam Nguyen, Deputy Director of Research, St Vincent's Hospital Melbourne
25th June 11:30-12:00
Capital Warming Up: "Where is the Spring Breeze of Financing Blowing" in the Innovative Biopharmaceutical Field"
Speaker:
Zhang Liang, Partner at Yueyin Medical Fund
25th June 14:00-14:20
Clinical Perspective: Clinical Needs and Emerging Biotherapy Clinical Trial Strategies (Proposed)
Speaker:
Gaobo Hospital PI (TBD)
25th June 14:20:14:40
Application of Translational Biomarkers in Accelerating Clinical Drug Development
Speaker:
Wan Xuechao, Head of Translational Medicine, Clinical Division of Shiyi Group
25th June 14:40:15:00
AI+Medical Era: Frontier Medical Innovation and Clinical Precision Medicine Practice
Speaker:
Lou Jingwei, Executive Dean of Shanghai Zhangjiang Medical Innovation Research Institute, Chairman of Shanghai Baoteng Biomedicine Technology Co., Ltd.
25th June 15:00-15:20
Preclinical and Clinical Research on Targeted Regulation of Breast Cancer Lineage Plasticity
Speaker:
Peng Peng, Vice President of Project Management at Yaojie Ankang
25th June 15:20-15:40
Biomarkers and Translational Medicine Empowering Clinical Success of Drugs (Proposed)
Speaker:
Tao Xiaolu, Senior Vice President of Translational Medicine and Early Development at Harbour BioMed (TBD)
25th June 15:40-16:30
Roundtable Discussion: Building a Translational Medicine Innovation Ecosystem Through Full Industry Chain Collaboration
Speaker:
Lou Jingwei, Executive Dean of Shanghai Zhangjiang Medical Innovation Research Institute, Chairman of Shanghai Baoteng Biomedicine Technology Co., Ltd.
25th June 16:30-17:00
Panel discussion
Copyright © 2025. All rights reserved. Informa Markets, a trading division of Informa PLC.